EDGAR Filing Documents for 0001193125-22-181473

Form 8-K - Current report:

SEC Accession No. 0001193125-22-181473

Filing Date

2022-06-24

Accepted

2022-06-24 16:06:15

Documents

Period of Report

2022-06-21

Items

Item 5.07: Submission of Matters to a Vote of Security Holders
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Interactive Data

Document Format Files

Seq	Description	Document	Type	Size
1	8-K	d356529d8k.htm iXBRL	8-K	33003
2	EX-99.1	d356529dex991.htm	EX-99.1	56241
6	GRAPHIC	g356529ex99_1p10g1.jpg	GRAPHIC	307479
7	GRAPHIC	g356529ex99_1p11g1.jpg	GRAPHIC	310273
8	GRAPHIC	g356529ex99_1p12g1.jpg	GRAPHIC	228264
9	GRAPHIC	g356529ex99_1p13g1.jpg	GRAPHIC	243974
10	GRAPHIC	g356529ex99_1p14g1.jpg	GRAPHIC	291056
11	GRAPHIC	g356529ex99_1p15g1.jpg	GRAPHIC	236444
12	GRAPHIC	g356529ex99_1p16g1.jpg	GRAPHIC	287773
13	GRAPHIC	g356529ex99_1p17g1.jpg	GRAPHIC	424702
14	GRAPHIC	g356529ex99_1p18g1.jpg	GRAPHIC	216273
15	GRAPHIC	g356529ex99_1p19g1.jpg	GRAPHIC	102599
16	GRAPHIC	g356529ex99_1p1g1.jpg	GRAPHIC	89416
17	GRAPHIC	g356529ex99_1p20g1.jpg	GRAPHIC	345631
18	GRAPHIC	g356529ex99_1p21g1.jpg	GRAPHIC	293380
19	GRAPHIC	g356529ex99_1p22g1.jpg	GRAPHIC	288282
20	GRAPHIC	g356529ex99_1p23g1.jpg	GRAPHIC	380896
21	GRAPHIC	g356529ex99_1p24g1.jpg	GRAPHIC	321054
22	GRAPHIC	g356529ex99_1p25g1.jpg	GRAPHIC	403786
23	GRAPHIC	g356529ex99_1p26g1.jpg	GRAPHIC	267747
24	GRAPHIC	g356529ex99_1p27g1.jpg	GRAPHIC	274653
25	GRAPHIC	g356529ex99_1p28g1.jpg	GRAPHIC	70751
26	GRAPHIC	g356529ex99_1p29g1.jpg	GRAPHIC	312695
27	GRAPHIC	g356529ex99_1p2g1.jpg	GRAPHIC	592203
28	GRAPHIC	g356529ex99_1p30g1.jpg	GRAPHIC	376150
29	GRAPHIC	g356529ex99_1p31g1.jpg	GRAPHIC	308722
30	GRAPHIC	g356529ex99_1p32g1.jpg	GRAPHIC	56641
31	GRAPHIC	g356529ex99_1p33g1.jpg	GRAPHIC	261110
32	GRAPHIC	g356529ex99_1p34g1.jpg	GRAPHIC	312026
33	GRAPHIC	g356529ex99_1p35g1.jpg	GRAPHIC	330980
34	GRAPHIC	g356529ex99_1p36g1.jpg	GRAPHIC	293717
35	GRAPHIC	g356529ex99_1p37g1.jpg	GRAPHIC	350990
36	GRAPHIC	g356529ex99_1p38g1.jpg	GRAPHIC	312721
37	GRAPHIC	g356529ex99_1p39g1.jpg	GRAPHIC	222516
38	GRAPHIC	g356529ex99_1p3g1.jpg	GRAPHIC	334475
39	GRAPHIC	g356529ex99_1p40g1.jpg	GRAPHIC	208182
40	GRAPHIC	g356529ex99_1p41g1.jpg	GRAPHIC	251671
41	GRAPHIC	g356529ex99_1p42g1.jpg	GRAPHIC	371101
42	GRAPHIC	g356529ex99_1p4g1.jpg	GRAPHIC	309992
43	GRAPHIC	g356529ex99_1p5g1.jpg	GRAPHIC	365267
44	GRAPHIC	g356529ex99_1p6g1.jpg	GRAPHIC	264986
45	GRAPHIC	g356529ex99_1p7g1.jpg	GRAPHIC	82671
46	GRAPHIC	g356529ex99_1p8g1.jpg	GRAPHIC	394686
47	GRAPHIC	g356529ex99_1p9g1.jpg	GRAPHIC	318413
	Complete submission text file	0001193125-22-181473.txt		16793071

Data Files

Seq	Description	Document	Type	Size
3	XBRL TAXONOMY EXTENSION SCHEMA	dawn-20220621.xsd	EX-101.SCH	2864
4	XBRL TAXONOMY EXTENSION LABEL LINKBASE	dawn-20220621_lab.xml	EX-101.LAB	18739
5	XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE	dawn-20220621_pre.xml	EX-101.PRE	11713
49	EXTRACTED XBRL INSTANCE DOCUMENT	d356529d8k_htm.xml	XML	3493

Mailing Address 395 OYSTER POINT BLVD STE 217 SOUTH SAN FRANCISCO CA 94080-1930

Business Address 395 OYSTER POINT BLVD STE 217 SOUTH SAN FRANCISCO CA 94080-1930 206-913-4300

Day One Biopharmaceuticals, Inc. (Filer) CIK: 0001845337 (see all company filings)